Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Outline of the Tender Offer 1) Offeror in the Public Tender Offer Autumn Acquisition Corporation 2) Company Subject to the Public Tender Offer Astex Pharmaceuticals, Inc. 3) Type of Stock that is to be Acquired All issued and outstanding shares of ...
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described “Euro mutt,” joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Astex Pharmaceuticals Inc Stock Downgraded (ASTX)
ASTEX PHARMACEUTICALS INC has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Related articles »  
Acquisition of Astex Pharmaceuticals, Inc. by Otsuka Pharmaceutical Co., Ltd ...
SAN DIEGO and DUBLIN, Calif., Sept. 5, 2013 /PRNewswire via COMTEX/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Astex Pharmaceuticals, Inc. ASTX ("Astex") by Otsuka Pharmaceutical Co., Ltd. ("Otsuka").
Japan's Otsuka to Buy US Cancer Drug Maker Astex for $886 Million  Wall Street Journal
Otsuka Bid for Astex Seen Undervaluing Cancer-Drug Maker  Bloomberg
Related articles »  
Buy, Sell, or Hold: Astex Pharmaceuticals
Let's take a look at Astex Pharmaceuticals (NASDAQ: ASTX ) today and see why you might want to buy, sell, or hold it. Founded in 1991 and based in California, Astex is a biotech company that specializes in small-molecule therapeutics and focuses ...
Related articles »  
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
In the 21st century investor's toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Related articles »  
Astex Pharma shareholder opposes $886 million bid by Otsuka
T) $886 million bid for Astex Pharmaceuticals Inc ASTX.O has run into opposition from an activist shareholder who says the deal significantly undervalues the U.S.
Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals  PR Newswire (press release)
Astex Pharmaceuticals Issues Open Letter to Stockholders Regarding Otsuka ...  GlobeNewswire (press release)
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Astex Pharma To Submit IND Application To FDA For ASTX727 - Quick Facts  RTT News
Related articles »  
Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals ...
“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it - perhaps other words like over-hyped, overvalued, risky, etc.
Is the Biotech Bubble About to Burst?  Motley Fool
Related articles »